Table 3.
Docosahexaenoic acid (DHA)a (μmoles/mL) | |||
---|---|---|---|
Group | Baseline | 4th weekc | 7th weekd |
| |||
Control | 0.64 ± 0.52 | 0.48 ± 0.39 | 0.34 ± 0.18 |
Fish Oil Supplemented | 0.60 ± 0.31 | 0.43 ± 0.14 | 0.32 ± 0.16 |
p-value | 0.86 | 0.77 | 0.85 |
Synaptamideb (fmoles/mL) | |||
| |||
Group | Baseline | 4th week | 7th week |
| |||
Control | 181.3 ± 46.3 | 110.3 ± 55.2 | 85.5 ± 33.3 |
Fish Oil Supplemented | 142.5 ± 33.9 | 134.3 ± 63.1 | 119.9 ± 40.0 |
p-value | 0.11 | 0.48 | 0.12 |
DHA concentration determined by GC/FID.
Synaptamide concentration determined by LC-MS/MS.
3.3 ± 0.8 weeks
6.9 ± 0.5 weeks.